7-75769746-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001371938.1(CCL26):āc.232A>Gā(p.Lys78Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000176 in 1,612,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001371938.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL26 | NM_001371938.1 | c.232A>G | p.Lys78Glu | missense_variant | 3/3 | ENST00000005180.9 | NP_001358867.1 | |
CCL26 | NM_001371936.1 | c.232A>G | p.Lys78Glu | missense_variant | 4/4 | NP_001358865.1 | ||
CCL26 | NM_006072.4 | c.232A>G | p.Lys78Glu | missense_variant | 4/4 | NP_006063.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL26 | ENST00000005180.9 | c.232A>G | p.Lys78Glu | missense_variant | 3/3 | 1 | NM_001371938.1 | ENSP00000005180 | P1 | |
CCL26 | ENST00000394905.2 | c.232A>G | p.Lys78Glu | missense_variant | 4/4 | 1 | ENSP00000378365 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000382 AC: 96AN: 251398Hom.: 0 AF XY: 0.000442 AC XY: 60AN XY: 135894
GnomAD4 exome AF: 0.000182 AC: 266AN: 1460532Hom.: 0 Cov.: 29 AF XY: 0.000248 AC XY: 180AN XY: 726732
GnomAD4 genome AF: 0.000118 AC: 18AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74494
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at